Congress Park Capital LLC Bristol Myers Squibb CO Transaction History

Congress Park Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$47.98 - $54.4 $227,904 - $258,400	4,750 New	4,750 $257,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $18,155 - $19,995	-250 Reduced 8.33%	2,750 $212,000
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $184,440 - $221,160	3,000 New	3,000 $219,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $225,971 - $246,083	-3,650 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$57.74 - $65.43 $8,661 - $9,814	150 Added 4.29%	3,650 $226,000
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $201,005 - $222,740	3,500 New	3,500 $211,000
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $324,243 - $471,200	-6,988 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $343,879 - $448,559	6,988 New	6,988 $449,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Congress Park Capital LLC with notifications on news.